EUVIMED · CrossrefJournal
Journal of Bone and Mineral Research
ISSN 0884-0431 · Oxford University Press (OUP)
Latest articles
International Consensus on Clinical Trial Endpoints in Autosomal Dominant Osteopetrosis
Undertreatment of Osteoporosis Following Fracture Among Older Women: Racial and Ethnic Disparities in a Medicare Claims–Based Cohort
Bone Phenotype by HR-pQCT Relates to Risk of Skeletal Complications After Spinal Fusion Surgery
Porcupine inhibition alleviates excessive bone formation in osteopathia striata with cranial sclerosis
The PTH responsive transcription factor NFIL3 regulates bone and energy metabolism
Colocalization between bone loading and metabolic activity in the human tibia in response to acute exercise
A Crisis in the Treatment of Osteoporosis - 10 Years Later, the US Care Gap is Still Open
2026 Annual Meeting of the American Society for Bone and Mineral Research, October 9-12, 2026
Investigating Factors Influencing the Long-Term Outcome of Teriparatide Treatment on the Risk of Hip Fracture. Is sequential treatment essential?
Opportunistic Osteoporosis Screening Using CT-Derived Volumetric Bone Mineral Density Reference Curves
Unraveling the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
Effects of anti-RANKL, zoledronate, or combination therapy in a mouse model of fibrous dysplasia: a preclinical study
Dissecting primary versus secondary effects of osteogenesis imperfecta on abnormal lung development and function
Expected change: a new concept for monitoring patients on oral bisphosphonates
Epidemiology of midlife fracture: self-reported and hospital episode data from the UK Biobank
A population-based cohort study of fracture risk among 122 255 adults before and after cancer diagnosis compared with matched controls
Predicting fracture risk after non-recent high risk fracture: improving accuracy with simple modifiers to FRAX
Associations of osteoporosis, sarcopenia, and osteosarcopenia with mortality: a comparative analysis for different sarcopenia definitions in the Manitoba and NHANES populations
Validating the FRAC-Stroke score: targeting those at highest risk of fracture
Cost-savings from fracture prevention with zoledronate in randomized controlled trials
Validating fracture risk after stoke: a call to action to optimize skeletal health after stroke?
Vertebral fractures in a young woman: the impact of hypogonadism, glucocorticoids, and chronic disease
Bone fragility: time to address the matrix
Is zoledronic acid cost-saving in daily practice?
Correction to: Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease
Correction to: The impact of segmentation approach on HR-pQCT microarchitectural and biomechanical metrics depends on bone structure
Effects of anti-RANKL, zoledronate or combination therapy in a mouse model of fibrous dysplasia: a preclinical study (Editorial)
Osteosarcopenia revisited: from mechanisms to management
Muscle function, linear growth, and bone health during 30 months of vamorolone, prednisone, and deflazacort treatment for Duchenne muscular dystrophy: a comparative study
Targeted long-read sequencing reveals allele-specific methylation profiles at the GNAS locus in pseudohypoparathyroidism with various etiologies
Volumes
2026 · 2112025 · 1752024 · 2082023 · 1282022 · 12021 · 252020 · 9332019 · 2772018 · 2972017 · 3162016 · 2952015 · 2892014 · 2982013 · 2832012 · 2882011 · 3212010 · 3152009 · 2462008 · 2512007 · 2712006 · 2732005 · 3052004 · 2812003 · 3152002 · 2862001 · 3072000 · 3041999 · 3031998 · 2391997 · 2761996 · 2701995 · 2901994 · 2631993 · 2291992 · 2291991 · 2361990 · 2281989 · 1351988 · 1111987 · 87
EUVIMED